Cardiovascular Systems, Inc.

NasdaqGS:CSII Stock Report

Market Cap: US$844.0m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Cardiovascular Systems Dividend

Dividend criteria checks 0/6

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.90
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

Feb 03
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely

Oct 12
We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely

Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates

Aug 03

Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns

Nov 05
Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns

Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?

Oct 09
Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?

At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?

Sep 18
At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?

Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?

Jun 24
Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?

Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Jun 03
Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?

We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow

Apr 29
We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow

Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Mar 17
Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain

Feb 10
Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain

Cardiovascular Systems misses on revenue

Feb 03

Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares

Dec 11
Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares

Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation

Nov 06

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CSII's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CSII's dividend payments have been increasing.


Dividend Yield vs Market

Cardiovascular Systems Dividend Yield vs Market
How does CSII dividend yield compare to the market?
SegmentDividend Yield
Company (CSII)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Medical Equipment)1.8%
Analyst forecast in 3 Years (CSII)0%

Notable Dividend: Unable to evaluate CSII's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CSII's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CSII has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.